Back
PharmaCorp Rx, Inc. 10K Form
Sell
39
PCRX.V
PharmaCorp Rx, Inc.
Last Price:
$0.42
Seasonality Move:
95.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PCRX.V News And Ratings
See the #1 stock for the next 7 days that we like better than PCRX.V
PCRX.V Financial Statistics
Sales & Book Value
| Annual Sales: | $5.8M |
|---|---|
| Cash Flow: | $537.5K |
| Price / Cash Flow: | 124.13 |
| Annual Sales: | $0.26 |
| Price / Book: | 1.67 |
Profitability
| EPS (TTM): | 0.00150 |
|---|---|
| Net Income (TTM): | $182.6K |
| Gross Margin: | $294.7K |
| Return on Equity: | 0.6% |
| Return on Assets: | 0.51% |
PharmaCorp Rx, Inc. Earnings Forecast
Key PharmaCorp Rx, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for PCRX.V is 5.09%.
-
The Selling, General & Administrative Expenses for PCRX.V have been equal to 8.90% of Gross Profit Margin.
-
The Net Earning history of PCRX.V is -18.13% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 2 years.
PharmaCorp Rx, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSXV |
|---|---|
| Industry: | Consumer Staples Distribution & Retail |
| Sector: | Consumer Staples |
| Current Symbol: | PCRX.V |
| Website: | pharmacorprx.ca/ |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.53 |
| Quick Ratio: | 1.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PCRX.V Technical Analysis vs Fundamental Analysis
Sell
39
PharmaCorp Rx, Inc. (PCRX.V)
is a Sell
Is PharmaCorp Rx, Inc. a Buy or a Sell?
-
PharmaCorp Rx, Inc. stock is rated a SellThe current PharmaCorp Rx, Inc. [PCRX.V] share price is $0.42. The Score for PCRX.V is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.